These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1482704)

  • 61. Cell lineage study in the liver using retroviral mediated gene transfer. Evidence against the streaming of hepatocytes in normal liver.
    Bralet MP; Branchereau S; Brechot C; Ferry N
    Am J Pathol; 1994 May; 144(5):896-905. PubMed ID: 8178942
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Human alpha 1-antitrypsin gene transfer to in vivo mouse hepatocytes.
    Aliño SF; Bobadilla M; Crespo J; Lejarreta M
    Hum Gene Ther; 1996 Mar; 7(4):531-6. PubMed ID: 8800748
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Retroviral-mediated gene transfer into hepatocytes in vivo.
    Ferry N; Duplessis O; Houssin D; Danos O; Heard JM
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8377-81. PubMed ID: 1656443
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Non-viral ex vivo hepatic gene transfer by in situ lipofection of liver and intraperitoneal transplantation of hepatocytes.
    Rangarajan PN; Vatsala PG; Ashok MS; Srinivas VK; Habibullah CM; Padmanaban G
    Gene; 1997 Apr; 190(1):217-21. PubMed ID: 9185870
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Experimental Model for Successful Liver Cell Therapy by Lenti TTR-YapERT2 Transduced Hepatocytes with Tamoxifen Control of Yap Subcellular Location.
    Yovchev M; Jaber FL; Lu Z; Patel S; Locker J; Rogler LE; Murray JW; Sudol M; Dabeva MD; Zhu L; Shafritz DA
    Sci Rep; 2016 Jan; 6():19275. PubMed ID: 26763940
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Heterologous protein expression by transimmortalized differentiated liver cell lines derived from transgenic mice (hepatomas/alpha 1 antitrypsin/ONC mouse).
    Dalemans W; Perraud F; Le Meur M; Gerlinger P; Courtney M; Pavirani A
    Biologicals; 1990 Jul; 18(3):191-8. PubMed ID: 2257132
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Towards liver-directed gene therapy: retrovirus-mediated gene transfer into human hepatocytes.
    Grossman M; Raper SE; Wilson JM
    Somat Cell Mol Genet; 1991 Nov; 17(6):601-7. PubMed ID: 1767337
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The human alpha-1-antitrypsin gene is efficiently expressed from two tissue-specific promotors in transgenic mice.
    Rüther U; Tripodi M; Cortese R; Wagner EF
    Nucleic Acids Res; 1987 Sep; 15(18):7519-29. PubMed ID: 3498933
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Retroviral mediated transfer and expression of human alpha 1-antitrypsin in cultured cells.
    Ledley FD; Grenett HE; Bartos DP; Woo SL
    Gene; 1987; 61(1):113-8. PubMed ID: 3502102
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Receptor-mediated gene delivery in vivo. Partial correction of genetic analbuminemia in Nagase rats.
    Wu GY; Wilson JM; Shalaby F; Grossman M; Shafritz DA; Wu CH
    J Biol Chem; 1991 Aug; 266(22):14338-42. PubMed ID: 1860843
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Therapeutic levels of human protein C in rats after retroviral vector-mediated hepatic gene therapy.
    Cai SR; Kennedy SC; Bowling WM; Flye MW; Ponder KP
    J Clin Invest; 1998 Jun; 101(12):2831-41. PubMed ID: 9637717
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clonal gene therapy: transplanted mouse fibroblast clones express human alpha 1-antitrypsin gene in vivo.
    Garver RI; Chytil A; Courtney M; Crystal RG
    Science; 1987 Aug; 237(4816):762-4. PubMed ID: 3497452
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Human gene therapy: present and future.
    Kay MA; Ponder KP; Woo SL
    Breast Cancer Res Treat; 1992; 21(2):83-93. PubMed ID: 1627818
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In vivo delivery of human alpha 1-antitrypsin gene to mouse hepatocytes by liposomes.
    Aliño SF; Bobadilla M; Garcia-Sanz M; Lejarreta M; Unda F; Hilario E
    Biochem Biophys Res Commun; 1993 Apr; 192(1):174-81. PubMed ID: 8476419
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Expression of human alpha 1-antitrypsin using a recombinant adenovirus vector.
    Gilardi P; Courtney M; Pavirani A; Perricaudet M
    FEBS Lett; 1990 Jul; 267(1):60-2. PubMed ID: 2365091
    [No Abstract]   [Full Text] [Related]  

  • 76. Cutting edge: treatment of complement regulatory protein deficiency by retroviral in vivo gene therapy.
    Spitzer D; Wu X; Ma X; Xu L; Ponder KP; Atkinson JP
    J Immunol; 2006 Oct; 177(8):4953-6. PubMed ID: 17015675
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Promoter/enhancer cassettes for keratinocyte gene therapy.
    Sawamura D; Meng X; Ina S; Nakano H; Tamai K; Nomura K; Hanada K; Miyazaki JI; Hashimoto I
    J Invest Dermatol; 1999 May; 112(5):828-30. PubMed ID: 10233782
    [No Abstract]   [Full Text] [Related]  

  • 78. Xenogeneic liver models for gene therapy.
    Vandendriessche T; Chuah MK
    Hum Gene Ther; 2010 Jan; 21(1):1-4. PubMed ID: 20043710
    [No Abstract]   [Full Text] [Related]  

  • 79. Regulation of hepatocyte-specific gene expression.
    Grayson DR; Costa RH; Darnell JE
    Ann N Y Acad Sci; 1989; 557():243-55, discussion 255-6. PubMed ID: 2472089
    [No Abstract]   [Full Text] [Related]  

  • 80. Gene therapy in heart disease.
    Smith LC; Eisensmith RC; Woo SL
    Adv Exp Med Biol; 1995; 369():79-88. PubMed ID: 7598019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.